[1] World Health Organization (2012) Depression Fact Sheet.
http://www.who.int/mediacentre/factsheets/fs369/en/
[2] Lee, S., Tsang, A. and Kwok, K. (2007) Twelve-Month Prevalence, Correlates, and Treatment Preference of Adults with DSM-IV Major Depressive Episode in Hong Kong. Journal of Affective Disorders, 98, 129-136.
http://dx.doi.org/10.1016/j.jad.2006.07.009
[3] National Collaborating Centre for Mental Health (UK) (2010) Depression: The Treatment and Management of Depression in Adults. National Institute for Health and Clinical Excellence: Guidance, The British Psychological Society & The Royal College of Psychiatrists, Leicester.
[4] Bayat, N., Alishiri, G.H., Salimzadeh, A., Izadi, M., Saleh, D.K., Lankarani, M.M. and Assari, S. (2011) Symptoms of anxiety and Depression: A Comparison among Patients with Different Chronic Conditions. Journal of Research in Medical Sciences, 16, 1441-1447.
[5] Hasler, G. (2010) Pathophysiology of Depression: Do We Have Any Solid Evidence of Interest to Clinicians? World Psychiatry, 9, 155-161.
http://dx.doi.org/10.1002/j.2051-5545.2010.tb00298.x
[6] Holsboer, F. and Ising, M. (2010) Stress Hormone Regulation: Biological Role and Translation into Therapy. Annual Review of Psychology, 61, 81-109.
http://dx.doi.org/10.1146/annurev.psych.093008.100321
[7] Werner, F.M. and Coveñas, R. (2010) Classical Neurotransmitters and Neuropeptides Involved in Major Depression: A Review. International Journal of Neuroscience, 120, 455-470.
http://dx.doi.org/10.3109/00207454.2010.483651
[8] Leonard, B.E. (2010) The Concept of Depression as a Dysfunction of the Immune System. Current Immunology Reviews, 6, 205-212.
http://dx.doi.org/10.2174/157339510791823835
[9] Zunszain, P.A., Anacker, C., Cattaneo, A., Carvalho, L.A. and Pariante, C.M. (2011) Glucocorticoids, Cytokines and Brain Abnormalities in Depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 722-729.
http://dx.doi.org/10.1016/j.pnpbp.2010.04.011
[10] Medscape (2014) Monoamine Oxidase Inhibitor Toxicity.
http://emedicine.medscape.com/article/815695-overview
[11] Kong, L.D., Cheng, C.H.K. and Tan, R.X. (2001) Monoamine Oxidase Inhibitors from Rhizoma of Coptis chinensis. Planta Medica, 67, 75-76.
http://dx.doi.org/10.1055/s-2001-10874
[12] Reeves, R.R. and Ladner, M.E. (2010) Antidepressant-Induced Suicidality: An Update. CNS Neuroscience & Therapeutics, 16, 227-234.
http://dx.doi.org/10.1111/j.1755-5949.2010.00160.x
[13] DuRubeis, R.J., Siegle, G.J. and Hollon, S.D. (2008) Cognitive Therapy versus Medication for Depression: Treatment Outcomes and Neural Mechanisms. Nature Reviews Neuroscience, 9, 788-796.
http://dx.doi.org/10.1038/nrn2345
[14] Kong, Y.C. (2005) The Cultural Fabric of Chinese Medicine: How to Know Your Body through Chinese Medicine. The Commercial Press, Hong Kong.
[15] Tsim, K.W.K. (2015) The Genesis of Traditional Chinese Medicine, “The Divine Farmer’s Herb-Root Classic”.
http://www.master-insight.com/content/article/2911
[16] Hong, H. (2014) The Theory of Chinese Medicine: A Modern Interpretation. Imperial College Press, London.
http://dx.doi.org/10.1142/p933
[17] Levine, R.L., Fredericks, W.R. and Rapoport, S.I. (1982) Entry of Bilirubin into the Brain Due to Opening of the Blood-Brain Barrier. Pediatrics, 69, 255-259.
[18] Kim, S.H., Han, J., Seog, D.H., Chung, J.Y., Kim, N., Park, Y.H. and Lee, S.K. (2005) Antidepressant Effect of Chaihu-Shugan-San Extract and Its Constituents in Rat Models of Depression. Life Sciences, 76, 1297-1306.
http://dx.doi.org/10.1016/j.lfs.2004.10.022
[19] Liu, Y., Ma, S. and Qu, R. (2010) SCLM, Total Saponins Extracted from Chaihu-jia-longgu-muli-tang, Reduced Chronic Mild Stress-Induced Apoptosis in the Hippocampus in Mice. Pharmaceutical Biology, 48, 840-848.
http://dx.doi.org/10.3109/13880200903296154
[20] Qiu, J., Hu, S.Y., Zhang, C.H., Shi, G.Q., Wang, S.E. and Xiang, T. (2014) The Effect of Chaihu-Shugan-San and Its Components on the Expression of ERK5 in the Hippocampus of Depressed Rats. Journal of Ethnopharmacology, 152, 320-326.
http://dx.doi.org/10.1016/j.jep.2014.01.004
[21] Mizoguchi, K., Yuzurihara, M., Ishige, A., Aburada, M. and Tabira, T. (2003) Saiko-ka-ryukotsu-borei-to, a Herbal Medicine, Ameliorates Chronic Stress-Induced Depressive State in Rotarod Performance. Pharmacology Biochemistry & Behavior, 75, 419-425.
http://dx.doi.org/10.1016/s0091-3057(03)00131-x
[22] Mizoguchi, K., Yuzurihara, M., Ishige, A., Sasaki, H. and Tabira, T. (2002) Saiko-ka-ryukotsu-borei-to, a Herbal Medicine, Prevents Chronic Stress-Induced Disruption of Glucocorticoid Negative Feedback in Rats. Life Sciences, 72, 67-77.
http://dx.doi.org/10.1016/S0024-3205(02)02199-9
[23] Tamano, H. and Takeda, A. (2004) Suppressive Effect of Saiko-ka-ryukotsu-borei-to, a Herbal Medicine, on Excessive Release of Glutamate in the Hippocampus. Brain Research Bulletin, 64, 273-277.
http://dx.doi.org/10.1016/j.brainresbull.2004.07.013
[24] Martinou, J.C. and Youle, R.J. (2011) Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics. Developmental Cell, 21, 92-101.
http://dx.doi.org/10.1016/j.devcel.2011.06.017
[25] Morel, N. (2003) Neurotransmitter Release: The Dark Side of the Vacuolar-H+ ATPase. Biology of the Cell, 95, 453-457.
http://dx.doi.org/10.1016/S0248-4900(03)00075-3
[26] Chen, Y.A. and Scheller, R.H. (2001) SNARE-Mediated Membrane Fusion. Nature Reviews Molecular Cell Biology, 2, 98-106.
http://dx.doi.org/10.1038/35052017
[27] Cosker, K.E., Courchesne, S.L. and Segal, R.A. (2008) Action in the Axon: Generation and Transport of Signaling Endosomes. Current Opinion in Neurobiology, 18, 270-275.
http://dx.doi.org/10.1016/j.conb.2008.08.005